Skip to content

APOTHEEK WOLFS

Active
Private limited companyfounded 200719 yrs activeAlbert Bevernagelei 89, 2100 Antwerpen, BelgiumKBO/BCE: BE 0889.535.332

APOTHEEK WOLFS has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €615k and a net result of €112k. Equity is growing by ~8.4% per year across the filed fiscal years. Its solvency ranks better than 79% of 10252 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2025
84 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability84▼-3
Solvency92▼-1
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €50k at 30 days acceptable
Liquidity ample (current ratio 2.64 against 2.6 in 2024; short-term debt: 32% and cash: 48.3% of total assets), and 32.9% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
67.1%
Return on assets
12.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 19 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-03-2026, 147 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
147 d early
2024
154 d early
2023
168 d early
2022
152 d early
2021
26 d early
2020
38 d early
2019
42 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Source amounts without an identifiable currency are assumed to be EUR.

Equity
€615k▲ 6.9%
2024 · €576k
2018: €354k 2019: €383k 2020: €383k 2021: €346k 2022: €445k 2023: €522k 2024: €576k
2018 → 2025
Total assets
€917k▲ 8.4%
2024 · €846k
2018: €550k 2019: €495k 2020: €535k 2021: €443k 2022: €717k 2023: €719k 2024: €846k
2018 → 2025
Net result
€112k▼ 6.9%
2024 · €120k
2018: €46k 2019: €67k 2020: €72k 2021: €90k 2022: €140k 2023: €124k 2024: €120k
2018 → 2025
Working capital
€482k▲ 14.5%
2024 · €421k
2018: €193k 2019: €331k 2020: €288k 2021: €315k 2022: €264k 2023: €345k 2024: €421k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€346k-€445k▲ 28.4%€522k▲ 17.3%€576k▲ 10.3%€615k▲ 6.9%
Operating result€128k-€208k▲ 62.5%€184k▼ 11.6%€189k▲ 2.7%€179k▼ 5.2%
Net result€90k-€140k▲ 55.0%€124k▼ 11.5%€120k▼ 2.5%€112k▼ 6.9%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2021: €128k€128kNet result 2021: €90k€90kOperating result 2022: €208k€208kNet result 2022: €140k€140kOperating result 2023: €184k€184kNet result 2023: €124k€124kOperating result 2024: €189k€189kNet result 2024: €120k€120kOperating result 2025: €179k€179kNet result 2025: €112k€112k20212022202320242025
The operating result falls in 2025; 2025 is 5% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €917k
Fixed assets €141k▼ 13.1%
Current assets €776k▲ 13.5%
Equity and liabilities €917k
Equity €615k▲ 6.9%
Debt €301k▲ 11.5%
The debt ratio rises from 32.0% to 32.9%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€202k
2024 · €212k
Cash flow
€136k
2024 · €144k
Solvency
67.1%
2024 · 68.0%
Current ratio
2.64
2024 · 2.60
Quick ratio
2.41
2024 · 2.33
Debt / equity
0.49
2024 · 0.47
ROE
18.2%
2024 · 20.9%
ROA
12.2%
2024 · 14.2%
Interest coverage
9.15
2024 · 11.24
Debt
€301k
2024 · €270k
Debt ≤ 1 year
€294k
2024 · €263k
Income taxes
€47k
2024 · €51k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€846k€917k
Fixed assets21/28€163k€141k
Tangible fixed assets22/27€163k€141k
Land and buildings22€128k€111k
Plant, machinery and equipment23€28k€26k
Furniture and vehicles24€6k€5k
Current assets29/58€683k€776k
Stocks and contracts in progress3€72k€67k
Stocks30/36€72k€67k
Amounts receivable within one year40/41€80k€79k
Trade receivables40€80k€79k
Other amounts receivable41€8€5
Current investments50/53€156k€168k
Cash at bank and in hand54/58€358k€443k
Deferred charges and accrued income490/1€18k€19k
Equity and liabilities
Total equity and liabilities10/49€846k€917k
Equity10/15€576k€615k
Contributions10/11€19k€19k=
Reserves13€557k€597k
Distributable reserves133€557k€597k
Amounts payable17/49€270k€301k
Amounts payable within one year42/48€263k€294k
Trade debts44€56k€45k
Suppliers440/4€56k€45k
Taxes, remuneration and social security45€19k€16k
Taxes450/3€19k€16k
Other amounts payable47/48€188k€233k
Accrued charges and deferred income492/3€8k€8k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€24k€23k
Other operating charges640/8€3k€4k
Gross operating margin9900€216k€206k
Operating profit (loss)9901€189k€179k
Financial income75/76B€2k€2k
Recurring financial income75€2k€2k
Financial charges65/66B€19k€22k
Recurring financial charges65€19k€22k
Profit (loss) for the period before taxes9903€171k€159k
Income taxes67/77€51k€47k
Profit (loss) for the period9904€120k€112k
Profit (loss) for the period to be appropriated9905€120k€112k
Appropriation of the result
Profit (loss) to be appropriated9906€120k€112k
Transfer from equity791/2€67k€72k
Transfer to equity691/2€120k€112k
To other reserves6921€120k€112k
Profit to be distributed694/7€67k€72k
Return on contributions (dividend)694€67k€72k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
06-03
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
27-02
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
14-02
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Equity above €500kEq €522k ▲17.3%
6 profitable years in a row build equity to €522k.
01-03
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Highest result since 2018net €140k ▲55%
Operating result €208k, net result €140k, both a record.
05-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
23-06
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
19-06
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial Liquidity doublescurrent ratio 4.57
Current ratio from 2.01 to 4.57; short-term debt falls from €192k to €93k.
24-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
19-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
07-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2007
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Albert Bevernagelei 892100 Antwerpen
Ground area
288 m²
Building footprint
143 m²
Volume, LiDAR
1,224 m³
Parcel 11012A0120/00D005, Flanders · tallest building 10.6 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
BVBA Wolfs
Albert Bevernagelei 89, 2100 AntwerpenNACE 70203
since 20072.164.741.575
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11012A0120/00D005 Flanders 288 m² 1 · 143 m² 10.6 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2024 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid
Year Entries awardedpaid
2024 1 2,000 EUR2,000 EUR
Schemes
Hinderpremie bij openbare werken
1 entry · 2,000 EUR · 2,000 EUR paid · Fonds voor Innoveren en Ondernemen

Recognitions · licences · registrations

Food safety, FASFC

1 site
Antwerpen2.164.741.575
1 permission
Apotheek (LM>3 maand) · since 01-04-2011

Similar companies · same sector, comparable size

Of 5,224 companies in sector 47730 we hold annual accounts for 3,863. 3,281 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded21-05-2007
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47750Retail sale of cosmetics and toilet articles
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers

Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.